Jan 29, 2025
Zofran, approved by the FDA in 1991, was originally for chemotherapy-related nausea. It's used off-label for morning sickness in pregnant women, leading to lawsuits since 2015 claiming birth defects like heart anomalies. Although GlaxoSmithKline insists on proper warnings, families seek legal recourse. Significantly, Zofran exposure in pregnancy is widespread, with...
4 Min Read